The average one-year price target for Cogent Biosciences (NasdaqGS:COGT) has been revised to $48.13 / share. This is an increase of 10.58% from the prior estimate of $43.52 dated November 14, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $34.34 to a high of $68.25 / share. The average price target represents an increase of 24.13% from the latest reported closing price of $38.77 / share.
What is the Fund Sentiment?
There are 357 funds or institutions reporting positions in Cogent Biosciences. This is an increase of 11 owner(s) or 3.18% in the last quarter. Average portfolio weight of all funds dedicated to COGT is 0.30%, an increase of 44.43%. Total shares owned by institutions increased in the last three months by 16.70% to 168,407K shares. 
The put/call ratio of COGT is 0.44, indicating a bullish outlook.
What are Other Shareholders Doing?
Deerfield Management Company, L.p. holds 9,053K shares representing 5.95% ownership of the company. In its prior filing, the firm reported owning 2,640K shares , representing an increase of 70.84%. The firm increased its portfolio allocation in COGT by 476.81% over the last quarter.
Fairmount Funds Management holds 9,003K shares representing 5.92% ownership of the company. In its prior filing, the firm reported owning 6,226K shares , representing an increase of 30.85%. The firm increased its portfolio allocation in COGT by 100.88% over the last quarter.
Kynam Capital Management holds 7,886K shares representing 5.19% ownership of the company. In its prior filing, the firm reported owning 8,493K shares , representing a decrease of 7.69%. The firm increased its portfolio allocation in COGT by 28.43% over the last quarter.
Commodore Capital holds 7,250K shares representing 4.77% ownership of the company. In its prior filing, the firm reported owning 2,311K shares , representing an increase of 68.12%. The firm increased its portfolio allocation in COGT by 333.91% over the last quarter.
TCG Crossover Management holds 6,798K shares representing 4.47% ownership of the company. In its prior filing, the firm reported owning 6,964K shares , representing a decrease of 2.44%. The firm decreased its portfolio allocation in COGT by 15.92% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
